CureMetrix - Model cmAngio - Investigational AI-Based Triage Software

cmAngio produces a CureMetrix Bradley ScoreTM based on the existence and characteristics of breast arterial calcifications in the mammogram. This proprietary score can then be used to help the care team assess the patient’s risk of CHD directly from their mammogram. The Bradley Score and their associated risk of CHD can be tracked over time to help patients and doctors understand their changing health profile.

Once validated, cmAngio can be used as a clinical decision support tool that will enable physicians and healthcare teams to:

• Identify women with a risk of coronary heart disease identified during routine breast cancer screening using mammography
• Enable clinical protocols that allow women at risk to be seen by their primary care physicians or cardiologists
• Help identify women who are at risk and might otherwise have gone undiagnosed until other more serious symptoms became apparent